NCT01127256View on ClinicalTrials.gov

Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

July 31, 2009

Conditions
Epilepsy
Interventions
DRUG

zonisamide

Initial dose was 100mg/day, increased by 100mg. The maximum dose was 600mg/day.

DRUG

carbamazepine

Initial dose was 100mg/day, increased by 200mg every 1 week to 600mg/day. The maximum dose was 1200mg/day.

Trial Locations (12)

Unknown

Seoul National Univ. Bundang Hosp., Bundang

Dongguk Univ. Ilsan Hosp., Ilsan

Inha Univ. Hosp., Incheon

Chungnam National Univ. Hosp., Jungnam

Boramae Medical Center, Seoul

Eulji General Hosp., Seoul

Ewha Womans Univ. Mokdong Hospital, Seoul

Hallym Univ. Medical Center, Seoul

Hanyang Univ. Medical Center, Seoul

Konkuk Univ. Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National Univ. Hosp., Seoul

All Listed Sponsors
lead

Eisai Korea Inc.

INDUSTRY

NCT01127256 - Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation | Biotech Hunter | Biotech Hunter